The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
Scholars, analysts, and companies cannot agree on what Amgen v. Sanofi means for patients, drug makers, and innovation.
patent
-
Read more: The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients -
Read more: Reclaiming Global Public Health Reclaiming Global Public Health
The promise of COVID vaccines has been unevenly realized: fault lines have emerged between those able to secure doses and those left behind.
-
Read more: No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge
This post explains why Moderna’s cynical attempt to take back its COVID-19 vaccine patent pledge should fail.
-
Read more: COVID-19, Patents, and Trade Secrets COVID-19, Patents, and Trade Secrets
Has the global distribution of COVID-19 vaccines been impacted by patent rights? David Gindler and Jasper L. Tran argue that the story is complicated.
-
Read more: COVID ‘Compromise’ on International IP Underscores Need for New Approach COVID ‘Compromise’ on International IP Underscores Need for New Approach
For COVID treatments and diagnostics to be broadly available at affordable prices, their IP must be considered a global public good.
-
Read more: Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics Using Contracts to Lessen Inequities in Access to Medicines in Pandemics and Epidemics
Research funding contracts can help to safeguard against inequities in global allocation and distribution of lifesaving diagnostics, drugs, and vaccines.
-
Read more: Decolonizing the Pandemic Treaty Through Vaccine Equity Decolonizing the Pandemic Treaty Through Vaccine Equity
Putting vaccine equity at the center of a pandemic treaty will already be a huge step towards global health’s decolonization.
-
Read more: The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good
The pandemic has laid bare the lack of regulation for the sharing of intellectual property needed for an effective and equitable response.
-
Read more: Promoting Vaccine Equity Promoting Vaccine Equity
The COVID-19 pandemic has brought into sharp relief longstanding equity problems surrounding the allocation of newly developed vaccines.
-
Read more: Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic
Activists in the access-to-medicines movement have mobilized to combat the threat of vaccine/therapeutic apartheid during the COVID-19 pandemic.